Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Navneet Majhail, MD

216.444.2199

Navneet Majhail, MD

Appointed: 2013

Navneet Majhail, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2199
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr Navneet Majhail, MD, MS is the Director of the Cleveland Clinic's Blood & Marrow Transplant Program. He serves as a Staff Physician with the Department of Hematology and Oncology at the Taussig Cancer Institute and is a Professor of Medicine with the Cleveland Clinic Lerner College of Medicine. Prior to joining the Cleveland Clinic, Dr Majhail has held appointments as Adjunct Associate Professor of Medicine with the University of Minnesota and as Medical Director Health Services Research at the National Marrow Donor Program, both in Minneapolis. His research focuses on the prevention and management of early and late complications of blood and marrow transplantation and health policy issues such as health care disparities, quality of care, survivorship and economic issues related to transplant.

Education & Fellowships

Fellowship - University of Minnesota
Hematology/Oncology
Minneapolis, MN USA
2007
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
2004
Other - All India Institute of Medical Sciences
Radiation Oncology
New Delhi India
2000
Medical School - Government Medical College
Chandigarh India
1996
Graduate - University of Minnesota
Minneapolis, MN USA

Certifications

  • Internal Medicine- Hematology
  • Internal Medicine

Specialty Interests

Blood and Marrow Transplantation, Leukemia, Lymphoma, Myeloma, Myelofibrosis, Aplastic Anemia, Other Hematologic Cancers Blood and Marrow Transplantation, Leukemia, Lymphoma, Myeloma, Other Hematologic Cancers

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/3/2014, Dr. Majhail has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English